XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Schedule of Information by Segment | The following table presents the significant segment expenses (10% or greater) and other segment items regularly reviewed by the Company’s CODM and included in research and development costs for the three months and March 31, 2026 and 2025. Schedule of Information by Segment
|  | 2026 |  |  | 2025 |
|  | Three Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Clinical and related oversight costs |  | $ | 309,794 |  |  | $ | 15,868 |
Preclinical research focused on development of additional novel anti-cancer compounds |  |  | 23,582 |  |  |  | 42,770 |
Regulatory service costs |  |  | - |  |  |  | 32,819 |
Total research and development costs |  | $ | 333,376 |  |  | $ | 91,457 |
The following table presents a summary of research and development costs for the three months ended March 31, 2026 and 2025 based on the respective geographical regions where such costs were incurred.
|  | 2026 |  |  | 2025 |
|  | Three Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
United States |  | $ | 38,972 |  |  | $ | 58,571 |
Spain |  |  | 294,404 |  |  |  | 32,886 |
Total |  | $ | 333,376 |  |  | $ | 91,457 |
The following table presents the significant segment expenses (10% or greater) and other segment items regularly reviewed by the Company’s CODM and included in general and administrative costs for the three months ended March 31, 2026 and 2025.
|  | 2026 |  |  | 2025 |
|  | Three Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Compensation: |  |  |  |  |  |  |  |
Cash based compensation |  | $ | 213,434 |  |  | $ | 108,731 |
Stock-based compensation |  |  | 82,176 |  |  |  | 99,738 |
Patent and licensing legal and filing fees and costs |  |  | 35,032 |  |  |  | 56,084 |
Marketing and public relations |  |  | 481,900 |  |  |  | - |
Accounting and bookkepping services |  |  | 254,744 |  |  |  | 41,909 |
Audit and legal |  |  | 195,846 |  |  |  | 134,103 |
Consulting fees |  |  | 181,856 |  |  |  | 29,303 |
Insurance expense |  |  | 64,387 |  |  |  | 64,277 |
Other costs and expenses, net |  |  | 144,656 |  |  |  | 81,338 |
Total general and administrative costs |  | $ | 1,654,031 |  |  | $ | 615,483 |

X
- Definition Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration